New Gelato Phenotype Released by Grow Pharma UK

Grow Pharma UK, one of the country's pioneering domestic medical cannabis producers, has announced the release of a new Gelato phenotype developed through their controlled pharmaceutical cultivation programme. The release represents the latest in a series of strain-specific products designed to offer UK patients consistent, high-quality alternatives to imported flower.

About the New Gelato Phenotype

The new phenotype has been selected for its refined cannabinoid profile — featuring THC concentrations in the range of 20 to 22 per cent alongside a terpene-rich profile dominated by caryophyllene, limonene, and myrcene. These terpenes are associated with relaxation, mood elevation, and anti-inflammatory properties respectively.

The product has undergone full pharmaceutical GMP testing and is available exclusively through the medical cannabis prescription route. Each batch is accompanied by a certificate of analysis confirming cannabinoid potency, terpene composition, and the absence of pesticide residues and heavy metals.

About Gelato as a Medical Strain

Gelato is a hybrid cannabis strain with an indica-dominant character that has been widely used in the medical market. Patients frequently report its effects as deeply relaxing without being sedating, with mood-lifting properties that make it popular among those managing anxiety, stress, and mild to moderate pain.

You can read a full profile of the Gelato strain — including detailed information on its cannabinoid ratios, effects, flavour characteristics, and patient use cases — in our Gelato strain guide.

UK-Grown Cannabis: The Advantages

• Reduced import logistics mean faster availability and potentially lower costs
• Domestic cultivation is subject to UK regulatory oversight throughout the supply chain
• Shorter supply chains can support product freshness and terpene preservation
• UK producers contribute to the domestic cannabis medicine industry and associated employment

Accessing Grow Pharma Products

Grow Pharma products are available through specialist medical cannabis clinics and their associated pharmacy dispensing partners. Patients interested in the new Gelato phenotype should discuss it with their prescribing doctor at their next consultation. To find a clinic, visit our clinic directory.